Jerry W. Mitchell

724 total citations · 1 hit paper
14 papers, 399 citations indexed

About

Jerry W. Mitchell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jerry W. Mitchell has authored 14 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jerry W. Mitchell's work include Cancer-related cognitive impairment studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer survivorship and care (3 papers). Jerry W. Mitchell is often cited by papers focused on Cancer-related cognitive impairment studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer survivorship and care (3 papers). Jerry W. Mitchell collaborates with scholars based in United States and Australia. Jerry W. Mitchell's co-authors include Charles E. Heckler, Michelle C. Janelsins, Karen M. Mustian, Alison Conlin, Lora Weiselberg, Charles Kamen, Luke J. Peppone, Ian R. Kleckner, Gary R. Morrow and Supriya G. Mohile and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Jerry W. Mitchell

11 papers receiving 391 citations

Hit Papers

Cognitive Complaints in Survivors of Breast Cancer After ... 2017 2026 2020 2023 2017 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study
    2017 270 citations Michelle C. Janelsins, Charles E. Heckler et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry W. Mitchell United States 7 284 164 135 61 61 14 399
Dolf Boerman Netherlands 5 179 0.6× 55 0.3× 198 1.5× 38 0.6× 17 0.3× 6 325
Jasmine Lai United States 6 278 1.0× 26 0.2× 226 1.7× 45 0.7× 42 0.7× 14 393
Minou Nadji‐Ohl Germany 12 88 0.3× 108 0.7× 158 1.2× 16 0.3× 39 0.6× 14 286
Adriani Kanellopoulos Norway 13 172 0.6× 93 0.6× 59 0.4× 25 0.4× 336 5.5× 16 505
Anne‐Katrin Hickmann Germany 14 82 0.3× 87 0.5× 158 1.2× 14 0.2× 33 0.5× 23 396
Carol K. Phebus United States 11 43 0.2× 42 0.3× 124 0.9× 21 0.3× 68 1.1× 14 374
Danièle Marceau Canada 4 56 0.2× 87 0.5× 17 0.1× 14 0.2× 51 0.8× 7 195
Takafumi Yamano Japan 10 108 0.4× 65 0.4× 10 0.1× 7 0.1× 16 0.3× 50 295
Jean Fergusson United States 7 149 0.5× 95 0.6× 157 1.2× 8 0.1× 282 4.6× 15 522
Michael Cotten United States 10 169 0.6× 13 0.1× 21 0.2× 6 0.1× 178 2.9× 17 454

Countries citing papers authored by Jerry W. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Jerry W. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry W. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry W. Mitchell more than expected).

Fields of papers citing papers by Jerry W. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry W. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry W. Mitchell. The network helps show where Jerry W. Mitchell may publish in the future.

Co-authorship network of co-authors of Jerry W. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry W. Mitchell. A scholar is included among the top collaborators of Jerry W. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry W. Mitchell. Jerry W. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gupta, Shilpa, Jessica Lee, Jerry W. Mitchell, & Richard S.P. Huang. (2025). Fibroblast Growth Factor Receptor 3 Alteration Status and Outcomes on Immune Checkpoint Inhibitors in Patients With Metastatic Urothelial Carcinoma. JCO Precision Oncology. 9(9). e2500257–e2500257.
2.
3.
Huang, Richard S.P., Chin‐Lin Tseng, Ethan Sokol, et al.. (2024). Clinical impact of UV mutational signatures in Veterans with cancer. The Oncologist. 30(8). 1 indexed citations
4.
Andrews, Miles C., Gerald Li, Ryon P. Graf, et al.. (2024). Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma. JCO Precision Oncology. 8(8). e2300640–e2300640. 8 indexed citations
5.
Williams, AnnaLynn M., Charles E. Heckler, Debra L. Barton, et al.. (2021). Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis. Breast Cancer Research and Treatment. 187(1). 275–285. 39 indexed citations
6.
Salerno, Elizabeth A., Eva Culakova, Amber S. Kleckner, et al.. (2021). Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study. Journal of Clinical Oncology. 39(29). 3283–3292. 42 indexed citations
7.
Tarhini, Ahmad A., Sandra J. Lee, Xiaoxue Li, et al.. (2018). E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma. Clinical Cancer Research. 25(2). 524–532. 6 indexed citations
8.
Janelsins, Michelle C., Charles E. Heckler, Luke J. Peppone, et al.. (2017). Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. Journal of Clinical Oncology. 35(5). 506–514. 270 indexed citations breakdown →
9.
Tarhini, Ahmad A., Sandra J. Lee, Uma N. M. Rao, et al.. (2017). A randomized phase II study of ipilimumab at 3 (ipi3) or 10 mg/kg (ipi10) alone or in combination with high dose interferon-alfa (HDI) in advanced melanoma (E3611).. Journal of Clinical Oncology. 35(15_suppl). 9542–9542. 1 indexed citations
10.
Paterson, Carly L., Ann M. O’Mara, Charles E. Heckler, et al.. (2017). Trajectories of anxiety among breast cancer patients treated with chemotherapy pre- and post-chemotherapy compared to healthy controls: A nationwide multicenter study.. Journal of Clinical Oncology. 35(15_suppl). e21711–e21711. 4 indexed citations
11.
Renfrow, Jaclyn J., Jerry W. Mitchell, Michael Goodman, et al.. (2013). Relapsing intracranial plasma cell granuloma: A case report. Oncology Letters. 7(2). 531–533. 7 indexed citations
12.
McDowell, Gladstone, Jerry W. Mitchell, & Timothy D. Moore. (2011). Use of Intrathecal Ziconotide for Frequent Severe and Intractable Sickle Cell Disease-Related Pain. Blood. 118(21). 1062–1062. 2 indexed citations
13.
McDowell, Gladstone, et al.. (2009). The use of intrathecal ziconotide to manage refractory malignant pain: Five case studies. Journal of Clinical Oncology. 27(15_suppl). e20737–e20737.
14.
Stratton, Pamela, Arlene Bardeguez, Deborah Cotton, et al.. (1992). Treatment options for human immunodeficiency virus‐infected pregnant women. International Journal of Gynecology & Obstetrics. 39(2). 151–151. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dolf Boerman Breakdown of academic impact, for papers by Jasmine Lai Breakdown of academic impact, for papers by Minou Nadji‐Ohl Breakdown of academic impact, for papers by Adriani Kanellopoulos Breakdown of academic impact, for papers by Anne‐Katrin Hickmann Breakdown of academic impact, for papers by Carol K. Phebus Breakdown of academic impact, for papers by Danièle Marceau Breakdown of academic impact, for papers by Takafumi Yamano Breakdown of academic impact, for papers by Jean Fergusson Breakdown of academic impact, for papers by Michael Cotten
Rankless by CCL
2026